Compounds > topotecan
Page last updated: 2024-08-24

topotecan and HIV Coinfection

topotecan has been researched along with HIV Coinfection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Beliakova-Bethell, N; Deshmukh, S; Mukim, A; Qazi, AA; Smith, DM1
Crumpacker, CS; Dezube, BJ; Li, CJ; Pardee, AB; Zhang, LJ1
Crumpacker, CS; Dezube, BJ; Li, CJ; Pardee, AB; Sharma, PL; Zhang, JL1
Learned, J1

Other Studies

5 other study(ies) available for topotecan and HIV Coinfection

ArticleYear
A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing.
    Journal of virology, 2023, 02-28, Volume: 97, Issue:2

    Topics: HIV Infections; Humans; Phosphoproteins; RNA Splicing; Serine-Arginine Splicing Factors; Topotecan; Virus Latency

2023
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Mar-01, Volume: 90, Issue:5

    Topics: Acute Disease; Antiviral Agents; Camptothecin; Cells, Cultured; Chronic Disease; Curcumin; Gene Expression Regulation, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; In Vitro Techniques; Naphthoquinones; RNA, Viral; Topotecan; Virus Replication

1993
Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5

    Topics: Camptothecin; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Topoisomerase I Inhibitors; Topotecan; Tumor Necrosis Factor-alpha; Virus Replication

1997
Topotecan now available for HIV, PML research.
    AIDS treatment news, 1995, Apr-07, Issue:no 220

    Topics: Antineoplastic Agents; Camptothecin; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan

1995
Topotecan and PML: the limits of pharmaceutical industry research.
    Notes from the underground (New York, N.Y.), 1996, Issue:No 33

    Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Camptothecin; Clinical Trials, Phase II as Topic; Consumer Advocacy; Drug Approval; Drug Evaluation, Preclinical; Drug Industry; Health Services Accessibility; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ovarian Neoplasms; Topotecan

1996